Sling Therapeutics
Sep 16, 2026 · Series C+
Sling Therapeutics Raises $123M Series C+ for Late-Stage Thyroid Eye Disease Therapy
Sling Therapeutics Secures $123M Series C+ Round Ann Arbor, Michigan based clinical stage biopharmaceutical company Sling Therapeutics has raised $123 million…
